Literature DB >> 32127183

Combination of Immunotherapy and Radiotherapy-The Next Magic Step in the Management of Lung Cancer?

Lizza E L Hendriks1, Jessica Menis2, Dirk K M De Ruysscher3, Martin Reck4.   

Abstract

Entities:  

Keywords:  Immune checkpoint inhibitors; NSCLC; Radiotherapy; SCLC

Year:  2020        PMID： 32127183     DOI： 10.1016/j.jtho.2019.12.106

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

Review 1.  Tumour burden and efficacy of immune-checkpoint inhibitors.

Authors:  Filippo G Dall'Olio; Aurélien Marabelle; Caroline Caramella; Camilo Garcia; Mihaela Aldea; Nathalie Chaput; Caroline Robert; Benjamin Besse
Journal:  Nat Rev Clin Oncol       Date:  2021-10-12       Impact factor: 66.675

Review 2.  How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review.

Authors:  Jordi Remon; Jessica Menis; Antonin Levy; Dirk K M De Ruysscher; Lizza E L Hendriks
Journal:  Transl Lung Cancer Res       Date:  2021-07

3.  Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.

Authors:  David Lang; Anna Brauner; Florian Huemer; Gabriel Rinnerthaler; Andreas Horner; Romana Wass; Elmar Brehm; Bernhard Kaiser; Richard Greil; Bernd Lamprecht
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

4.  Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue.

Authors:  Jae Myoung Noh; Yeon Jeong Kim; Ho Yun Lee; Changhoon Choi; Won-Gyun Ahn; Taeseob Lee; Hongryull Pyo; Jee Hyun Park; Donghyun Park; Woong-Yang Park
Journal:  Cancer Res Treat       Date:  2021-05-25       Impact factor: 4.679
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.